Thomas Logan, Mirion Chairman and CEO, Elected to Board of Directors of Nuclear Energy Institute
The Nuclear Energy Institute (NEI) announced that Thomas Logan, Mirion Chairman and Chief Executive Officer, has been elected to its Board of Directors. Elections took place during the organization’s Board meeting on May 12, 2026. NEI is the policy organization of the nuclear energy industry in the United States, representing the interests of the industry before Congress, the administration, and state and local governments.
Mirion, a leading provider of advanced radiation safety solutions, is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. Logan has led Mirion since its inception in 2005, and his election underscores Mirion’s ongoing role in shaping the future of the nuclear industry through innovation, operational excellence, and active engagement with industry partners.
“I’m pleased to join the NEI Board at a time of continued momentum for the nuclear industry," Logan said. "Collaboration across the sector will be essential as we innovate and advance safety and long-term growth in the U.S. and around the world, and I look forward to contributing alongside industry leaders in support of NEI’s mission.”
Logan has guided Mirion's growth as a global provider of radiation safety, measurement and nuclear technologies serving the energy, medical and defense sectors. He currently serves as chairman and CEO and has more than 30 years of experience across the energy and industrial technology industries.
In 2025, Mirion strengthened its nuclear industry expertise through the acquisitions of Paragon Energy Solutions and Certrec, expanding its capabilities across engineering support, regulatory compliance and operational solutions while deepening customer relationships throughout the operating fleet and emerging new nuclear market.
About Mirion
Mirion is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. Focused on nuclear and safety, the Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. Dedicated to driving better patient outcomes, the Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance the delivery and ensure safety across the medical landscape. Headquartered in Atlanta (GA – USA), Mirion employs approximately 3,200 people and operates in 12 countries. Learn more at mirion.com.
For media inquiries:
Erin Schesny
[email protected]
For investor inquiries:
Eric Linn
[email protected]